相似文献
1
Nonviral vector gene modification of stem cells for myocardial repair.
Mol Med. 2008 Jan-Feb;14(1-2):79-86. doi: 10.2119/2007-00092.Haider.
2
Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair.
J Am Heart Assoc. 2015 Sep 11;4(9):e002104. doi: 10.1161/JAHA.115.002104.
3
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
J Control Release. 2008 Dec 18;132(3):260-6. doi: 10.1016/j.jconrel.2008.06.024. Epub 2008 Jul 6.
4
Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
JACC Cardiovasc Imaging. 2009 Jul;2(7):869-79. doi: 10.1016/j.jcmg.2009.04.008.
5
Genetic modification of stem cells for improved therapy of the infarcted myocardium.
Mol Pharm. 2011 Oct 3;8(5):1446-57. doi: 10.1021/mp2001318. Epub 2011 Jun 8.
6
Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction.
Hum Gene Ther. 2010 Oct;21(10):1327-34. doi: 10.1089/hum.2010.006.
7
Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction.
J Control Release. 2015 May 10;205:218-30. doi: 10.1016/j.jconrel.2015.02.013. Epub 2015 Feb 11.
8
Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.
Exp Cell Res. 2009 Dec 10;315(20):3521-31. doi: 10.1016/j.yexcr.2009.09.026. Epub 2009 Oct 2.
9
Inhibition of Oct 3/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium.
Stem Cell Res Ther. 2015 Dec 24;6:259. doi: 10.1186/s13287-015-0252-5.
10
Adenovirus-mediated stromal cell-derived- factor-1alpha gene transfer induces cardiac preservation after infarction via angiogenesis of CD133+ stem cells and anti-apoptosis.
Interact Cardiovasc Thorac Surg. 2008 Oct;7(5):767-70. doi: 10.1510/icvts.2007.169896. Epub 2008 Jun 24.
引用本文的文献
1
Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair.
Physiol Rep. 2017 Nov;5(21). doi: 10.14814/phy2.13480.
2
Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology.
World J Stem Cells. 2017 Jan 26;9(1):9-25. doi: 10.4252/wjsc.v9.i1.9.
3
Enhanced non-viral gene delivery by coordinated endosomal release and inhibition of β-tubulin deactylase.
Nucleic Acids Res. 2017 Apr 7;45(6):e38. doi: 10.1093/nar/gkw1143.
4
Functional polymers of gene delivery for treatment of myocardial infarct.
J Control Release. 2014 Dec 10;195:110-9. doi: 10.1016/j.jconrel.2014.07.041. Epub 2014 Jul 27.
5
Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies.
Adv Exp Med Biol. 2012;741:171-86. doi: 10.1007/978-1-4614-2098-9_12.
6
Assessment and optimization of cell engraftment after transplantation into the heart.
Circ Res. 2010 Feb 19;106(3):479-94. doi: 10.1161/CIRCRESAHA.109.208991.
7
Stem cell paracrine actions and tissue regeneration.
Regen Med. 2010 Jan;5(1):121-43. doi: 10.2217/rme.09.74.
8
Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation.
J Control Release. 2010 Feb 25;142(1):61-9. doi: 10.1016/j.jconrel.2009.09.021. Epub 2009 Oct 7.
9
Angiomyogenesis for myocardial repair.
Antioxid Redox Signal. 2009 Aug;11(8):1929-44. doi: 10.1089/ars.2009.2471.
10
Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.
Stem Cell Rev. 2008 Spring;4(1):27-49. doi: 10.1007/s12015-008-9008-2.
本文引用的文献
1
Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair.
Circulation. 2007 Sep 11;116(11 Suppl):I113-20. doi: 10.1161/CIRCULATIONAHA.106.680124.
2
Characterization of the interplay between the main factors contributing to lipoplex-mediated transfection in cell cultures.
J Gene Med. 2007 Oct;9(10):884-93. doi: 10.1002/jgm.1079.
3
Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
Int J Pharm. 2007 Sep 5;342(1-2):33-9. doi: 10.1016/j.ijpharm.2007.04.035. Epub 2007 May 10.
4
Therapeutic angiogenesis with bone marrow--derived stem cells.
J Cardiovasc Pharmacol Ther. 2007 Jun;12(2):89-97. doi: 10.1177/1074248407303139.
5
Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran.
Tissue Eng. 2007 Feb;13(2):313-22. doi: 10.1089/ten.2006.0133.
6
SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.
FASEB J. 2007 Oct;21(12):3197-207. doi: 10.1096/fj.06-6558com. Epub 2007 May 11.
7
Nucleofection: a new method for cutaneous gene transfer?
J Biomed Biotechnol. 2006;2006(5):26060. doi: 10.1155/JBB/2006/26060.
8
Efficient transient genetic labeling of human CD34+ progenitor cells for in vivo application.
Regen Med. 2006 Mar;1(2):223-34. doi: 10.2217/17460751.1.2.223.
9
Complex formation with plasmid DNA increases the cytotoxicity of cationic liposomes.
Biol Pharm Bull. 2007 Apr;30(4):751-7. doi: 10.1248/bpb.30.751.
10
Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium.
J Mol Cell Cardiol. 2007 Apr;42(4):792-803. doi: 10.1016/j.yjmcc.2007.02.001. Epub 2007 Feb 8.
Zotero 插件